Managerial Economics offers the analytical portfolio that is required to work in the multi-billion dollar and high-pressure choices of the pharmaceutical industry. The most difficult task to many students and project managers is deciding on whether to greenlight a Phase III clinical trial. These are the costliest and most perilous phase of the drug development process where a No-Go decision can prevent a firm from monetary collapse, yet a Go- decision can result in a breakthrough treatment worth billions. With the help of a strong Decision Tree Model, we will be able to resolve the issue of uncertainty as we will be able to quantify the risks and the path to the maximum value.
Q: Build a decision tree model for a pharmaceutical company deciding whether to invest in Phase III clinical trials
The Issue: How to Overcome the Valley of Death in R&D
The asymmetric information and the unpredictability of success are the basic problems of the pharmaceutical management. A drug can be promising in Phase II, but in Phase III a larger number of patients are needed and there are more strict efficacy requirements. The managers are confronted with the Sunk Cost trap which makes them need to persist due to the earlier investments. Managerial Economics teaches that the decision should only be based on future costs and benefits. A decision tree is one such remedy to this psychological bias, both graphical and mathematical.
Need Help to Write Your Paper? Click Here To Order From an Expert
No Plagiarism; No AI; Only Human-Written Papers From Scratch. 100% Sure.
Creation of the Decision Tree Model in Managerial Economics
A Decision Tree Model is a step by step depiction of a decision problem. In our case study of pharmaceutical, we start with square Decision Node which is the decision: Invest in Phase III or Abandon Project.
- The Investment Path: This means that the company would spend a lot of money at once (e.g., 500 million) in case it invests.
- The Chance Nodes: These are circles that signify things that the manager cannot control. Phase III consists of two branches, which are usually FDA Approval (Success) and FDA Rejection (Failure).
- Probabilities: A manager may put a probability of 60 percent in success and 40 in failure based on historical data of the industry.
- Payoffs: These are the end of the road values. A high Net Present Value (NPV) shown by the estimated market share over the patent life is expected to occur in case of success, whereas a zero additional revenue (and the cost of the trial is also lost) is expected to occur in case of failure.
Computation of Expected Monetary Value (EMV)
We apply the Expected Monetary Value (EMV) in order to solve the optimal path. This is determined by summation of the product of the probability of both outcomes and their payoffs. For example:
EMV=(Psuccess×Payoffsuccess)+(Pfailure×Payofffailure)−CostTrial
When EMV of the Invest branch is considerably greater than the EMV of Abandon (which is typically zero, without the Opportunity Cost of capital), then according to the model, one should go ahead. This quantitative practice eliminates the emotion in the board room and ensures that the decision is in the best interest of the fiduciary duty of the firm to shareholder maximization.
The Sensitivity Analysis Role in Managerial Economics
In the practical Managerial Economics, probabilities do not tend to be definite. Sensitivity Analysis is where it is a key tool of problem-solving. The question that managers need to pose is this: at which point of probability of success does the project turn unprofitable? The company can calculate the break-even success rate by varying the inputs in the decision tree, i.e. discount rate or the estimated market size. Suppose the probability needed to have a positive EMV is 70 percent, whereas the historical success rate of this type of drug is 50 percent, the model gives a very clear message that this investment is too risky.
Connecting the Academic Theory with the Industry Reality
The trick with writing on this issue is that the complex Probability Theory needs to be combined with the business strategy as it is commonly the case with the students who are supposed to write on this subject matter. One has to not only draw a tree but give reasons as to why the numbers. This involves knowledge of Risk Analysis and Time Value of Money. When writing an academic term paper or a case study analysis, it is important to show how one can fold back the tree (going right to left to identify the best choice to make at first) to achieve a good grade.
Moreover, an analysis can be raised by the inclusion of Utility Theory. Though EMV makes the firm become a risk-neutral firm, most of the pharmaceutical firms are risk-averse to multi-billion dollar losses. Modifying the tree to mirror the Utility Function of the firm will give a more sophisticated, professional-level answer to the dilemma of R&D investment.
The Importance of Professional Expertise
The art of Mastering the complexities of Managerial Economics is a combination of a mathematical accuracy and a strategic vision. The data-intensive projects of creating proper Decision Tree Models or of performing a detailed Payoff Matrix analysis all overwhelm many students. A generic content is just not able to convey the technical standards required of a university level submission or a corporate report.
At HelpfulWriters.com, we fill this gap by making available subject-matter experts who are experts in healthcare economics and quantitative finance. We know that you have to depend on your research in order to improve your academic reputation.
- Originality Reports: All of our models and analyses are developed on a custom basis. Our originality reports are extensive to make sure your work is original and scholarly.
- Subject-Matter Expertise: Our authors are not simple researchers but experts who know all the regulatory and economic challenges in the pharmaceutical business.
- Strict Confidentiality: This is because we value your privacy and therefore, your partnership with us is strictly confidential.
Final Strategic Insights for Managerial Economics
Managerial Economics is used in decision trees to convert the gut feeling into an explainable, data-based strategy. By measuring risks of clinical trials in Phase III, the pharmaceutical companies will be able to safeguard their assets and invest their resources in the most promising life-saving innovations.
In case you are grappling with the mathematical dogma of EMV or the structural complexity of a decision tree, then you do not allow your academic performance to bring you down. Get ready your future in the sphere of management with the help of the experience of the professionals who know the theory and the result of its work.
Order your paper now at HelpfulWriters.com to have a personally-crafted yet academically sound paper, one that has come to grips with the finer aspects of decision-making. We will make your hardest economic issues easy and best to solve.